Oral decontamination with aminoglycosides is associated with lower risk of mortality and infections in high-risk patients colonized with colistin-resistant, KPC-producing Klebsiella pneumoniae

Journal of Antimicrobial Chemotherapy

Volumn 71, Issue 11, 2016, Pages 3242-3249

  Machuca, Isabel ^a   Gutiérrez Gutiérrez, Belén ^b   Pérez Cortés, Salvador ^c   Gracia Ahufinger, Irene ^a   Serrano, Josefina ^a   Madrigal, María Dolores ^c   Barcala, José ^c   Rodríguez López, Fernando ^a   Rodríguez Baño, Jesús ^b   Torre Cisneros, Julián ^a  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^c Hospital Universitario de Jerez   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; COLISTIN; GENTAMICIN; NEOMYCIN PLUS STREPTOMYCIN; UNCLASSIFIED DRUG; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; BETA LACTAMASE;

AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; COHORT ANALYSIS; COMORBIDITY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INFECTION RISK; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY RISK; NEUTROPENIA; NONHUMAN; PROPENSITY SCORE; RETROSPECTIVE STUDY; RISK REDUCTION; TREATMENT RESPONSE; ANTIBIOTIC RESISTANCE; CLINICAL TRIAL; DECONTAMINATION; DRUG EFFECTS; ENZYMOLOGY; HETEROZYGOTE; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTIONS; MICROBIOLOGY; MIDDLE AGED; MORTALITY; ORAL DRUG ADMINISTRATION; PROCEDURES; RISK ASSESSMENT; SECRETION (PROCESS); SURVIVAL ANALYSIS; TREATMENT OUTCOME; VERY ELDERLY;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CARRIER STATE; COLISTIN; DECONTAMINATION; DRUG RESISTANCE, BACTERIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84994482382     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkw272     Document Type: Article

References (25)

1. Tzouvelekis LS, Markogiannakis A, Psichogiou M et al. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev 2012; 25: 682-707.
2. Zarkotou O, Pournaras S, Tselioti P et al. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clin Microbiol Infect 2011; 17: 1798-803.
3. Tumbarello M, Viale P, Viscoli C et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemaseproducing K. pneumoniae: importance of combination therapy. Clin Infect Dis 2012; 55: 943-50.
4. Souli M, Galani I, Antoniadou A et al. An outbreak of infection due to b-lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes. Clin Infect Dis 2010; 50: 364-73.
5. Qureshi ZA, Paterson DL, Potoski BA et al. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens. Antimicrob Agents Chemother 2012; 56: 2108-13.
6. Patel G, Huprikar S, Factor SH et al. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008; 29: 1099-106.
7. Neuner EA, Yeh JY, Hall GS et al. Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections. Diagn Microbiol Infect Dis 2011; 69: 357-62.
8. KPC-containing Klebsiella pneumoniae in a long-termacute care hospital: a newchallenge to our healthcare system. J Antimicrob Chemother 2009; 64: 1102-10.
9. Munoz-Price LS, Quinn JP. Deconstructing the infection control bundles for the containment of carbapenem-resistant Enterobacteriaceae. Curr Opin Infect Dis 2013; 26: 378-87.
10. BuehlmannM, Bruderer T, Frei R et al. Effectiveness of a new decolonisation regimen for eradication of extended-spectrumb-lactamase-producing Enterobacteriaceae. J Hosp Infect 2011; 77: 113-7.
11. Zuckerman T, Benyamini N, Sprecher H et al. SCT in patients with carbapenem resistant Klebsiella pneumoniae: a single center experience with oral gentamicin for the eradication of carrier state. Bone Marrow Transplant 2011; 46: 1226-30.
12. Tascini C, Sbrana F, Flammini S et al. Oral gentamicin gut decontamination for prevention of KPC-producing Klebsiella pneumoniae infections: relevance of concomitant systemic antibiotic therapy. Antimicrob Agents Chemother 2014; 58: 1972-6.
13. Saidel-Odes L, Polachek H, Peled N et al. A randomized, double-blind, placebo-controlled trial of selective digestive decontamination using oral gentamicin and oral polymyxin E for eradication of carbapenemresistant Klebsiella pneumoniae carriage. Infect Control Hosp Epidemiol 2012; 33: 14-9.
14. Schechner V, Kotlovsky T, Kazma M et al. Asymptomatic rectal carriage of blaKPC producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected? Clin Microbiol Infect 2013; 19: 451-6.
15. Oren I, Sprecher H, Finkelstein R et al. Eradication of carbapenemresistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment: a prospective controlled trial. Am J Infect Control 2013; 41: 1167-72.
16. Zimmerman FS, Assous MV, Bdolah-Abram T et al. Duration of carriage of carbapenem-resistant Enterobacteriaceae following hospital discharge. Am J Infect Control 2013; 41: 190-4.
17. Gonzalez-Padilla M, Torre-Cisneros J, Rivera-Espinar F et al. Gentamicin therapy for sepsis due to carbapenem-resistant and colistinresistant Klebsiella pneumoniae. J Antimicrob Chemother 2015; 70: 905-13.
18. Dautzenberg MJ, Wekesa AN, Gniadkowski M et al. The association between colonization with carbapenemase-producing enterobacteriaceae and overall ICU mortality: an observational cohort study. Crit Care Med 2015; 43: 1170-7.
19. von Elm E, Altman DG, Egger M et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370: 1453-7.
20. Charlson ME, Pompei P, Ales KL et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83.
21. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36: 309-332.
22. Levy MM, Fink MP, Marshall JC et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit CareMed 2003; 31: 1250-6.
23. Lopez-Cerero L, Egea P, Gracia-Ahufinger I et al. Characterisation of the first ongoing outbreak due to KPC-3-producing Klebsiella pneumoniae (ST512) in Spain. Int J Antimicrob Agents 2014; 44: 538-40.
24. Daneman N, Sarwar S, Fowler RA et al. Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis. Lancet Infect Dis 2013; 13: 328-41.
25. Wittekamp BH, Bonten MJ. Antibiotic prophylaxis in the era of multidrug-resistant bacteria. Expert Opin Investig Drugs 2012; 21: 767-72.